slotkoers
Andere beurzen
|
||
- | - |
25/04 | Labcorp verslaat kwartaalramingen door sterke vraag naar tests | RE |
25/04 | Labcorp koopt failliete genetische testmaker Invitae voor $239 miljoen | RE |
Omzet 2021 | 460 mln. 0 426 mln. | Omzet 2022 | 516 mln. 0 477 mln. | Marktkapitalisatie | 452 mln. 0 418 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -379 mln. - -350 mln. | Nettowinst (verlies) 2022 | -3,11 mld. - -2,87 mld. | EV/omzet 2021 | 8,98 x |
Nettoschuld 2021 | 679 mln. 0 627 mln. | Nettoschuld 2022 | 1,2 mld. 0 1,11 mld. | EV/omzet 2022 | 3,21 x |
K/w-verhouding 2021 |
-8,5
x | K/w-verhouding 2022 |
-0,14
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 98,19% |
Recentste transcriptie over InVitae Corp
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Kenneth Knight
CEO | Chief Executive Officer | 63 | 29-06-20 |
Ana Schrank
DFI | Director of Finance/CFO | - | 02-10-23 |
David Sholehvar
COO | Chief Operating Officer | 56 | 13/11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 67 | 04-11-15 | |
Randal Scott
CEO | Chief Executive Officer | 66 | 13-01-10 |
Eric Aguiar
BRD | Director/Board Member | 62 | 01-09-10 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-27,01% | 10,26 mld. | |
+31,86% | 3,04 mld. | |
-8,58% | 2,94 mld. | |
-13,62% | 2,19 mld. | |
-16,32% | 1,72 mld. | |
+63,36% | 1,4 mld. | |
+27,00% | 780 mln. | |
-2,18% | 736 mln. | |
-19,18% | 560 mln. |